Sage Journals: Discover world-class research

Retricted access

Research article

First published 2018-10

Cladribine versus fingolimod,natalizumab and interferon β for multiple sclerosis

Tomas Kalincik, Vilija Jokubaitis, Tim Spelman [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2011-5

Safety and tolerability of cladribine tablets in multiple sclerosis: the CLARITY (CLAdRIbine Tablets treating multiple sclerosis orallY) study

S Cook, P Vermersch, G Comi [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2023-3

Cladribine and pregnancy in women with multiple sclerosis: The first cohort study

Karen Dost-Kovalsky, Sandra Thiel, Andrea I Ciplea [...]

Multiple Sclerosis Journal

Retricted access

Case report

First published 2021-4

Cladribine transfer into human milk: A case report

Palika Datta, Andrea I Ciplea, Kathleen Rewers-Felkins [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2019

Therapy with cladribine is efficient and safe in patients previously treated with natalizumab

Nora Möhn, Thomas Skripuletz, Kurt-Wolfram Sühs [...]

Therapeutic Advances in Neurological Disorders

Open access

Research article

First published 2024-7

Early clinical effect of cladribine in patients with highly active multiple sclerosis in Mexico

Sergio Sauri-Suarez, Sandra Quiñones, Manuel De la Maza-Flores [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Open access

Research article

First published 2018-10

Positive impact of cladribine on quality of life in people with relapsing multiple sclerosis

Dayo Afolabi, Christo Albor, Lukasz Zalewski [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2024-8

Effectiveness of cladribine compared to fingolimod,natalizumab,ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis

Izanne Roos, Sifat Sharmin, Charles Malpas [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2024

Cladribine tablets after treatment with natalizumab (CLADRINA) – rationale and design

Peter V. Sguigna, Rehana Z. Hussain, Annette Okai [...]

Therapeutic Advances in Neurological Disorders

Open access

Review article

First published 2025

Cladribine tablets in the new multiple sclerosis era

Fabio Buttari, Ettore Dolcetti, Francesca Romana Rizzo [...]

Therapeutic Advances in Neurological Disorders

Search results